Clinical Trial Update: Safety Study of Intravenous Hydromorphone Using Incremental 1mg Doses up to 2mg for Adult ED Patients [Phase 4]

View source ↗

Summary

Phase 4 safety study evaluating intravenous hydromorphone with incremental 1 mg doses up to 2 mg in adult emergency department patients; completed with results …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• Hydromorphone (hydromorphone)

Snippet

Sponsor: Montefiore Medical Center | Conditions: Pain | Phase 4 | Status: COMPLETED | Results posted: 2018-08-13